Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
P13727
UPID:
PRG2_HUMAN
Alternative names:
Proteoglycan 2
Alternative UPACC:
P13727; A6XMW0; B2R5I1; P81448; Q14227; Q6ICT2
Background:
Bone marrow proteoglycan, also known as Proteoglycan 2, plays a pivotal role in the human body. It functions as a cytotoxin and helminthotoxin, crucial for antiparasitic defense mechanisms and immune hypersensitivity reactions. Additionally, it induces non-cytolytic histamine release from human basophils and acts as a proteinase inhibitor in its proform, reducing the activity of PAPPA.
Therapeutic significance:
Understanding the role of Bone marrow proteoglycan could open doors to potential therapeutic strategies.